FDA Documents of Chongqing Daxin Pharmaceutical Co., Ltd.
Chongqing Daxin Pharmaceutical Co., Ltd. is an organization that has been audited by the FDA 8 times between 2001 and 2024 across all 5 sites.
Documents
FDA 483 Chongqing Daxin Pharmaceutical Co., Ltd., Beibei | 2024
Out-of-stock
Issued on: Jun 28, 2024
Human Drugs Form 483
FDA 483 Chongqing Daxin Pharmaceutical Co., Ltd., Chongqing | 2018
Out-of-stock
Issued on: May 11, 2018
Human Drug Form 483
FDA 483 Chongqing Daxin Pharmaceutical Co., Ltd., Chongqing | 2009
Out-of-stock
Issued on: Aug 6, 2009
Human Drug Form 483
FDA 483 Chongqing Daxin Pharmaceutical Co., Ltd., Chongqing | 2001
Out-of-stock
Issued on: Sep 25, 2001
Human Drug Form 483
FDA Investigators(10)
- Gavin T. Cua, FDA Investigator
- Joel D. Hustedt, FDA Investigator
- Sony Mathews, FDA Investigator
- Paul L. Bellamy, FDA Investigator
- Larry K. Austin, FDA Investigator
- Susan W. Ting, FDA Investigator
- Jose R. Hernandez, FDA Investigator
- Zi-Qiang Gu, FDA Investigator
- Charles M. Edwards, FDA Investigator
- Yvette I. Johnson, FDA Investigator